Cart is empty Development of potential or improved anti-cancer treatments is being blocked or slowed down by a lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers and consumers.
Development of potential or improved anti-cancer treatments is being blocked or slowed down by a lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers and consumers.
Leave A Comment